Early versus late response to PD-1-based immunotherapy in metastatic melanoma

Georg C. Lodde, Fang Zhao, Rudolf Herbst, Patrick Terheyden, Jochen Utikal, Claudia Pföhler, Jens Ulrich, Alexander Kreuter, Peter Mohr, Ralf Gutzmer, Friedegund Meier, Edgar Dippel, Michael Weichenthal, Philipp Jansen, Bernd Kowall, Wolfgang Galetzka, Fabian Hörst, Jens Kleesiek, Birte Hellwig, Jörg Rahnenführer, Luisa Rajcsanyi, Triinu Peters, Anke Hinney, Jan-Malte Placke, Antje Sucker, Annette Paschen, Jürgen C. Becker, Elisabeth Livingstone, Lisa Zimmer, Alpaslan Tasdogan, Alexander Roesch, Eva Hadaschik, Dirk Schadendorf, Klaus Griewank, Selma Ugurel
August, 2024
Cite DOI URL
Type
Journal article
Publication
European Journal of Cancer
Melanoma survival immunotherapy CTLA-4 PD-1 immune checkpoint inhibition best overall response PD-L1 therapy outcome
Fabian Hörst
Fabian Hörst
PhD Student
Jens Kleesiek
Jens Kleesiek
Professor of Translational Image-guided Oncology